Abstract
ADHD is a serious risk factor for co-occurring psychiatric disorders and negative psychosocial consequences in adulthood. Previous trials on psychotherapeutic concepts for adult ADHD are based on behavioural (cognitive behavioural and dialectical behavioural) psychotherapeutic approaches and showed significant effects. The aim of our study group (COMPAS) is to carry out a first randomized and controlled multicentre study to evaluate the effects of a disorder tailored psychotherapy in adult ADHD compared to clinical management in combination with psychopharmacological treatment or placebo. A total of 448 adults with ADHD according to DSM-IV will be treated at seven university sites in Germany. In a four-arm design, patients are randomized to a manualized dialectical behavioural therapy (DBT) based group programme plus methylphenidate or placebo or clinical management plus methylphenidate or placebo with weekly sessions in the first 12 weeks and monthly sessions thereafter. Therapists are graduated psychologists or physicians. Treatment integrity is established by independent supervision. Primary endpoint (ADHD symptoms measured by the Conners Adult Rating Scale) is rated by interviewers blind to the treatment allocation. Intention-to-treat analysis will be performed within a linear regression model (Current Controlled Trials ISRCTN54096201). The trial is funded by the German Federal Ministry of Research and Education (01GV0606) and is part of the German network for the treatment of ADHD in children and adults (ADHD-NET).
Similar content being viewed by others
References
Beck AT, Ward CH, Mendelson M, Mock H, Erbaugh J (1961) An inventory for measuring depression. Arch Gen Psychiatry 4:561–571
Biederman J (2004) Impact of comorbidity in adults with attention-deficit/hyperactivity disorder. J Clin Psychiatry 65 (Suppl 3): 3–7 (review)
Birnbaum HG, Kessler RC, Lowe SW et al (2005) Costs of attention deficit-hyperactivity disorder (ADHD) in the US: excess costs of persons with ADHD and their family members in 2000. Curr Med Res Opin 21(2):195–206
Bramham J, Young S, Bickerdike A, Spain D, McCartan D, Xenitidis K (2009) Evaluation of Group Cognitive Behavioral Therapy for Adults With ADHD. J Atten Disord 12(5):434–441
Brazier J, Roberts J, Deverill M (2002) The estimation of a preference-based measure of health from the SF-36. J Health Econ 21:271–292
Christiansen H, Kis B, Hirsch O, Philipsen A, Henneck M, Panczuk A, Pietrowsky R, Hebebrand J, Schimmelmann BG (2010) German validation of the Conners Adult ADHD Rating Scales-self-report (CAARS-S) I: Factor structure and normative data. Eur Psychiatry
Conners CK, Ehrhard D, Sparrow D (1999) CAARS adult ADHD rating scales. MHS, New York
Derogatis LR (1977) SCL-90-R: administration, scoring and procedures manual II. Clinical Psychometric Research, Towson, MD
Ebert D, Krause J, Roth-Sackenheim C (2003) ADHS im erwachsenenalter–leitlinien auf der basis eines expertkonsensus mit unterstutzung der DGPPN. Nervenarzt 74:939–946
Endicott J, Nee J, Harrison W, Blumenthal R (1993) Quality of life enjoyment and satisfaction questionnaire: a new measure. Psychopharmacol Bull 29(2):321–326
Faraone SV, Spencer T, Aleardi M et al (2004) Meta-analysis of the efficacy of methylphenidate for treating adult attention-deficit/hyperactivity disorder. J Clin Psychopharm 24:24–29
Franke GH (2002) SCL-90-R. Die symptom-checkliste von derogatis–deutsche version. Beltz, Weinheim
Guy W (1976). ECDEU Assessment manual for psychopharmacology
Hesslinger B, Tebartz van Elst L, Nyberg E et al (2002) Psychotherapy of attention deficit hyperactivity disorder in adults - A pilot study using a structured skills training program. Eur Arch Psychiatry Clin Neurosci 252:177–184
Hesslinger B, Philipsen A, Richter H (2003) Psychotherapy in adult ADHD. Verhaltenstherapie 13:276–282
Hesslinger B, Philipsen A, Richter H et al (2004) Psychotherapie der ADHS im Erwachsenenalter–ein Arbeitsbuch. Hogrefe, Goettigen
Jacob CP, Philipsen A, Ebert D et al (2008) Multimodale therapie der aufmerksamkeitsdefizit-/hyperaktivitaetsstoerung im erwachsenenalter. Nervenarzt 79:801–808
Knapp M, Mangalore R (2007) The trouble with QALYs. Epidemiol Psychiatr Soc 26:289–293
Lehrl S (1977) Mehrfachwahl-Wortschatz-Intelligenztest Form B. Straube, Erlangen
Linehan MM (1993) Cognitive-behavioral treatment of borderline personality disorder. Guildford Press, New York
Mannuzza S, Klein G, Bessler A et al (1998) Adult psychiatric status of hyperactive boys grown up. Am J Psychiatry 155:493–498
Matza LS (2007) Responsiveness of the adult attention-deficit/hyperactivity disorder quality of life scale (AAQoL). Qual Life Res 16:1511–1520
Medori R, Ramos-Quiroga JA, Casas M et al (2008) A randomized, placebo-controlled trial of three fixed dosages of prolonged-release OROS methylphenidate in adults with attention-deficit/hyperactivity disorder. Biol Psychiatry 63(10):981–989
Mick E, Faraone SV, Spencer T, Zhang HF, Biederman J (2008) Assessing the validity of the quality of life enjoyment and satisfaction questionnaire short form in adults with ADHD. J Atten Disord 11(4):504–509
Philipsen A (2006) Differential diagnosis and comorbidity of attentiondeficit/hyperactivity disorder (ADHD) and borderline personality disorder (BPD) in adults. Eur Arch Psychiatr Clin Neurosci 256(Suppl 1):i42–i46
Philipsen A, Richter H, Peters J et al (2007) Structured group psychotherapy in adults with attention deficit hyperactivity disorder: results of an open multicenter study. J Nerv Ment Dis 195:1013–1019
Philipsen A, Limberger MF, Lieb K et al (2008) Attention deficit/hyperactivity disorder as a potentially aggravating factor in borderline personality disorder. Br J Psychiatry 192:118–123
Philipsen A, Feige B, Hesslinger B et al (2009) Borderline typical symptoms in adult patients with attention deficit/hyperactivity disorder. ADHD Atten Defic Hyperact Disord 1:11–18
Retz-Junginger P, Retz W, Blocher D et al (2002) Wender utah rating scale (WURS-k). Nervenarzt 73:830–838
Retz-Junginger P, Retz W, Blocher D et al (2003) Reliabilitaet und Validitaet der Wender-Utah-Rating-Scale Kurzform. Retrospektive Erfassung von Symptomen aus dem Spektrum der Aufmerksamkeitsdefizit/Hyperaktivitaetsstoerung. Nervenarzt 74:987–993
Roesler M, Retz W, Retz-Junginger P et al (2004) Instrumente zur diagnostik der aufmerksamkeitsdefizit-/hyperaktivitaetsstoerung (ADHS) im Erwachsenenalter. Selbstbeurteilungsskala (ADHS-SB) und Diagnosecheckliste (ADHS-DC). Nervenarzt 75:888–895
Rösler M, Retz W, Stieglitz RD (2010) Psychopathological rating scales as efficacy parameters in adult ADHD treatment investigations–benchmarking instruments for international multicentre trials. Pharmacopsychiatry 43(3):92–98
Safren SA, Otto MW, Sprich STE et al (2005) Cognitive-behavioral therapy for ADHD in medication-treated adults with continued symptoms. Behav Res Ther 43:831–842
Salakari A, Virta M, Grönroos N et al (2010) Cognitive-behaviorally-oriented group rehabilitation of adults with ADHD: results of a 6-month follow-up. J Atten Disord 13(5):516–523
Schlander M (2007) Health technology assessments by the national institute for health and clinical excellence. A qualitative study. Springer, New York
Schlander M, Trott GE, Schwarz O (2010). The health economics of attention deficit hyperactivity disorder in Germany. Part 1: Health care utilization and cost of illness. Nervenarzt 81(3): 289–300 (review German)
Schmitz N, Hartkamp N, Kiuse J et al (2000) The symptom check-list-90-R (SCL-90-R): a German validation study. Qual Life Res 9(2):185–193
Secnik K, Swensen A, Lage MJ (2005) Comorbidities and costs of adult patients diagnosed with attention-deficit hyperactivity disorder. Pharmacoeconomics 23(1):93–102
Solanto MV, Marks DJ, Wasserstein J et al (2010) Efficacy of meta-cognitive therapy for adult ADHD. Am J Psychiatry 167(8):958–968
Stevenson CS, Whitmont S, Bornholt L et al (2002) A cognitive remediation programme for adults with attention deficit hyperactivity disorder. Austr New Z J Psychiatr 36:610–616
Virta M, Vedenpää A, Grönroos N et al (2008) Adults with ADHD benefit from cognitive-behaviorally oriented group rehabilitation: a study of 29 participants. J Atten Disord 12(3):218–226
Wender PH, Wolf LE, Wasserstein J (2001) Adults with ADHD: an overview. Ann NY Acad Sci 931:1–16
Wilens TE, Faraone SV, Biederman J (2004) Attention deficit/hyperactivity disorder in adults. JAMA 292(5):619–623
Wittchen HU, Zaudig M, Fydrich T (1997) SKID–strukturiertes klinisches interview fuer DSM IV. Achse I und II. Hogrefe, Goettingen
Zylowska L, Ackerman DL, Yang MH et al (2008) Mindfulness meditation training in adults and adolescents with ADHD: a feasibility study. J Atten Disord 11(6):737–746
Acknowledgments
Our network on psychotherapy of ADHD is supported by the German Federal Ministry of Education and Research (BMBF; 01GV0605, 01GV0606). Members of the COMPAS group (Comparison of methylphenidate and psychotherapy in adult ADHD study, coordinating investigator: PD Dr. A. Philipsen, Freiburg) are our colleagues at the study sites at Wuerzburg (Department of Child and Adolescent Psychiatry and Psychotherapy, Director: Prof. Dr. A. Warnke, coordinator of the ADHD-NET), Freiburg (Department of Psychiatry and Psychotherapy, Director: Prof. Dr. M. Berger), Homburg (Saarland University Hospital and Saarland University Faculty of Medicine: Institute for Forensic Psychology and Psychiatry, Director: Prof. Dr. M. Roesler), Mannheim (Central Institute for Mental Health: Clinic for Psychiatry and Psychotherapy, Director: Prof. Dr. A. Meyer-Lindenberg), Wuerzburg (Department of Psychiatry, Psychosomatics and Psychotherapy, Director: Prof. Dr. J. Deckert; Department of Child and Adolescent Psychiatry, Psychosomatics and Psychotherapy, Director: Prof. Dr. A. Warnke), Mainz (Department of Psychiatry and Psychotherapy, Director: Prof. K. Lieb; Department of Child and Adolescent Psychiatry and Psychotherapy, Director: Prof. M. Huss), Essen (Department of Psychiatry and Psychotherapy, Director: Prof. J. Wiltfang), members of the Clinical Trials Center at Freiburg (Director: Prof. Dr. H. Maier-Lenz) as well as members of the Data Monitoring and Safety Committee (Prof. Dr. Dr. H. Remschmidt, Prof. Dr. G. Wassmer, PD Dr. N. Wodarz). Independent supervision is carried out by staff members of the Institute for Psychology of Freiburg University in cooperation with colleagues in private practice. The three other projects of our network on psychotherapy of ADHD (coordinator: Prof. Dr. A. Warnke, Wuerzburg) are coordinated by Prof. A. Warnke and Dr. T. Jans (Wuerzburg, ADHD in Mothers and Children (AIMAC) Study), Prof. Dr. L. Tebartz van Elst (Freiburg, functional and morphometric brain mapping) and Prof. Dr. K.-P. Lesch (Wuerzburg, molecular genetics). We gratefully thank all participating patients and all our Partners for their cooperation. We feel obliged to Dr. Fischer (MEDICE Arzneimittel Puetter GmbH & Co. KG) for his support in providing the trial medication and in preparing the study protocol and case report forms as well as his assistance in SAE management. German Federal Ministry of Education and Research (Bundesministerium fuer Bildung und Forschung, BMBF, ref: 01GV0606). MEDICE Arzneimittel Pütter GmbH & Co. KG (trial medication).
Author information
Authors and Affiliations
Corresponding author
Additional information
For the COMPAS group (COMPAS: Comparison of methylphenidate and psychotherapy in adult ADHD study; study sites: University Medical Centers of Freiburg, Wuerzburg, Berlin, Saarland, Central Institute of Mental Health Mannheim, University Medical Centers Essen and Mainz).
Appendix
Appendix
-
Declaration of Helsinki: http://www.ohsr.od.nih.gov/helsinki.php3.
-
ICH-GCP-Guidelines: http://www.ich.org.
-
German GCP-bye-law (GCP-Verordnung, GCP-V) vom 09.08.2004, German Pharmaceuticals Act (Arzneimittelgesetz §40-42; 12. AMG-Novelle): http://www.ethik.meb.uni-bonn.de/amg12.html.
Rights and permissions
About this article
Cite this article
Philipsen, A., Graf, E., Tebartz van Elst, L. et al. Evaluation of the efficacy and effectiveness of a structured disorder tailored psychotherapy in ADHD in adults: study protocol of a randomized controlled multicentre trial. ADHD Atten Def Hyp Disord 2, 203–212 (2010). https://doi.org/10.1007/s12402-010-0046-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12402-010-0046-7